YG Entertainment to launch 'more than one' K-pop group in 2024
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
YG Entertainment and its founder and chief producer, Yang Hyun-suk, will announce “more than one” new K-pop group in 2024, and boy band Treasure will work on new music, the agency said Tuesday.
The company's statement may reassure critics who have expressed doubts over the future of YG Entertainment after its announcement that the four members of Blackpink would not renew their individual contracts.
“We aim to officially kick off projects to find and raise trainees through auditions in Korea and abroad, aiming to announce more than one rookie group within this year,” YG Entertainment said in a news release Tuesday, sharing the agency’s plan for 2024.
Treasure will also start preparing new music after completing its second Japanese tour, “Reboot,” in March.
Babymonster, YG Entertainment’s latest girl group, will drop a new digital single, “Stuck In The Middle,” on Feb. 2 followed by its first EP on April 1.
The agency did not, however detail any plans for its quartet Blackpink.
Yang will continue to lead the agency and its artists, YG added. Yang recently purchased 10 billion won ($7.48 million) worth of the agency’s stock.
To find out more about YG Entertainment, visit Celeb Confirmed!
BY CHO YONG-JUN [cho.yongjun1@joongang.co.kr]
Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.
- IU scraps 'Love wins' single title after online backlash
- Seoul to launch sales of unlimited transit pass next Tuesday
- Major supermarkets gain weekend trading freedom in gov't overhaul
- [EXCLUSIVE] Big Tech layoffs loom in Korea as furious workers revolt
- Temperatures to nosedive as big freeze's wintery grip tightens
- Yoshiki, G-Dragon Instagram post garners talk of possible collaboration
- OpenAI CEO Sam Altman will visit Korea to meet with Samsung, SK
- JYP's future uncertain as ITZY and NMIXX struggle to sell
- Gambling site suspects turned illegal proceeds into fast cars, fine art and fat stacks of cash
- [NEWS IN FOCUS] Watch out for 'biological missile drugs,' the next big thing in pharma